Drug diversion is an escalating problem in healthcare – one that affects patients, security, and reputation. Yet instances of drug diversion often go unreported.
It’s important for healthcare providers and those outside the clinical setting to tackle the issue of drug diversion head on. That’s why FairWarning is proud to sponsor the 2019 National Healthcare Facility Rx Diversion Summit (NADDI) in St. Petersburg, Florida on April 1-2, 2019. The Summit, organized by the National Association of Drug Diversion Investigators (NADDI), is an excellent opportunity to learn more about drug diversion and how to safely and effectively handle this growing problem.
The leading drug diversion training organization in the nation, NADDI has the largest networking platform for professionals in the area of pharmaceutical drug diversion. The Summit was designed to reach a range of stakeholders interested in or already involved in creating or enhancing proactive strategies and programs for addressing diversion.
2019 National Healthcare Facility Rx Diversion Summit
Location: Hilton Bayfront, St. Petersburg, FL
Date: April 1-2, 2019
For more information, visit the NADDI website.